Literature DB >> 1627553

Characterization of the alpha and beta subunits of casein kinase 2 by far-UV CD spectroscopy.

O G Issinger1, C Brockel, B Boldyreff, J T Pelton.   

Abstract

Although Chou-Fasman calculations of the secondary structure of recombinant casein kinase 2 subunits alpha and beta suggest they have a similar overall conformation, circular dichroism (CD) studies show that substantial differences in the conformation of the two subunits exist. In addition, comparison of the far-UV CD spectrum of reconstituted CK-2 with the spectra of the subunits indicates that conformational changes occur in the backbone region upon association. Such changes may explain the increased enzyme activity of the holoenzyme relative to that of the alpha subunit itself. In contrast, no changes in the far-UV CD spectrum of the alpha subunit are observed in the presence of casein or the synthetic decapeptide substrate RRRDDDSDDD. Furthermore, the alpha-helical structure of the alpha subunit (but not the beta subunit) can be increased in the presence of stoichiometric amounts of heparin, presumably by its binding to the polylysine stretch at amino acid positions 74-77. Heat denaturation experiments (25-90 degrees C) support the notion that heparin may provide a local protective function. A similar but much larger effect was also observed in the presence of the beta subunit only, which supports previous suggestions of a protective function for this subunit. These results indicate that the protection provided by the beta subunit and the increased enzyme activity of the holoenzyme may arise, in part, from a stabilization of the conformation of the enzyme complex and an increase in alpha-helical content.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627553     DOI: 10.1021/bi00141a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Intermolecular contact sites in protein kinase CK2.

Authors:  A Krehan; W Pyerin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme.

Authors:  K Niefind; B Guerra; I Ermakowa; O G Issinger
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

3.  Expression, purification and characterisation of a novel mutant of the human protein kinase CK2.

Authors:  Elena Grasselli; Graziano Noviello; Cristina Rando; Claudio Nicolini; Laura Vergani
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

4.  The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.

Authors:  Jennifer Raaf; Elena Brunstein; Olaf-Georg Issinger; Karsten Niefind
Journal:  Protein Sci       Date:  2008-09-29       Impact factor: 6.725

5.  Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.

Authors:  Birgitte B Olsen; Tine Rasmussen; Karsten Niefind; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2008-06-24       Impact factor: 3.396

6.  Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality.

Authors:  Thierry Buchou; Muriel Vernet; Olivier Blond; Hans H Jensen; Hervé Pointu; Birgitte B Olsen; Claude Cochet; Olaf-Georg Issinger; Brigitte Boldyreff
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

7.  Depletion of catalytic and regulatory subunits of protein kinase CK2 by antisense oligonucleotide treatment of neuroblastoma cells.

Authors:  L Ulloa; J Díaz-Nido; J Avila
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

8.  CK2beta gene silencing increases cell susceptibility to influenza A virus infection resulting in accelerated virus entry and higher viral protein content.

Authors:  Henju Marjuki; Christoph Scholtissek; Hui-Ling Yen; Robert G Webster
Journal:  J Mol Signal       Date:  2008-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.